gout
Advertisement
Abdul Abdellatif discussed findings from the PROTECT study examining pegloticase for kidney transplant patients with gout.
Aquapheresis may provide an alternative for fluid removal in hypervolemia patients with sickle cell nephropathy.
Researchers reported on a patient with elevated 1,25-dihydroxyvitamin D with hypercalcemia and severe tophaceous gout.
A case report suggests treatment with intravenous pegloticase could help eGFR recovery in patients with uncontrolled gout.
A study examined gout incidence and risk among stage 3-5 CKD patients with asymptomatic hyperuricemia.
A study examined the prevalence, patient characteristics, and medical management of patients with gout and CKD.
A patient with gout experienced an increased risk of kidney stone formation after adopting a carnivore diet.
Researchers presented bone-related findings of a study on pegloticase use in kidney transplant recipients with gout.
Researchers explored an association between fluctuating uric acid levels and adverse prognoses in older adults with CKD.
A study examined the association between the prescription of ULT and the progression of kidney disease in patients with CKD.
Recognizing and managing concurrent gout and CKD is important for improving outcomes but can be difficult.
Researchers studied the relationship between CKD and serum urate by assessing stage prevalence after first gout diagnosis.
There are few data available on the associations between serum urate levels and the risk of recurrent gout.
The presence of hyperechoic crystal deposition was associated with hyperuricemia as well as with ischemic nephropathy.
Serum uric acid level was an independent influence factor for cardiovascular disease, as well as kidney disease.
Patients with chronic hyperuricemia commonly develop gout, a painful inflammatory arthritis. Gout has been associated ...
Gout is a common form of inflammatory arthritis, affecting an estimated 3.9% of US adults. It is associated with high ...
Decline in renal function is associated with hyperuricemia and gout. Independent of chronic kidney disease (CKD) stage, ...
Results of the MIRROR randomized controlled trial comparing cotherapy of pegloticase plus methotrexate (MTX) with ...
Immunomodulator cotherapy has been shown to improve the efficacy of pegloticase by reducing its immunogenicity. Results ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.